Lipid nanoparticles deliver mRNA to the blood-brain barrier

被引：3

作者：

Kuzminich, Yanina ^{[1
,2
]}

Shakked, Avraham ^{[3
,4
]}

Calkins, Randi ^{[3
,4
]}

Rudden, Sebastian ^{[2
,3
,4
]}

Jones, Camille ^{[3
,4
]}

Doan, Jessie ^{[3
,4
]}

Jang, Bora ^{[3
,4
]}

Echeverri, Elisa Schrader ^{[3
,4
]}

Zenhausern, Ryan ^{[3
,4
]}

Lian, Liming ^{[3
,4
]}

Loughrey, David ^{[3
,4
]}

Peck, Hannah E. ^{[3
,4
]}

Wiese, Rachelle ^{[3
,4
]}

Koveal, Dorothy ^{[3
,4
]}

Santangelo, Philip J. ^{[3
,4
]}

Dahlman, James E. ^{[3
,4
]}

机构：

[1] Georgia Inst Technol, George C Woodruff Sch Mech Engn, Atlanta, GA 30332 USA

[2] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA

[3] Emory Univ, Wallace H Coulter Dept Biomed Engn, Sch Med, Atlanta, GA 30332 USA

[4] Georgia Inst Technol, Atlanta, GA 30332 USA

来源：

NANO RESEARCH | 2024年

基金：

美国国家科学基金会;

关键词：

lipid nanoparticle; mRNA; nanomedicine; central nervous system; blood-brain barrier; IN-VIVO; DISCOVERY; POTENT; CELLS;

D O I：

10.1007/s12274-024-6827-7

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

Lipid nanoparticles (LNPs) have delivered RNA to hepatocytes in patients after intravenous administration. These clinical data support efforts to design LNPs that transfect cells in the central nervous system (CNS). However, delivery to the CNS has been difficult, in large part because quantifying on-target delivery alongside common off-target cell types in adult mice remains challenging. Here we report methods to isolate different cell types from the CNS, and subsequently present mRNA delivery readouts using a liver-detargeted LNP. These data suggest that LNPs without targeting ligands can transfect cerebral endothelial cells in mice after intravenous administration. Given the difficulty of crossing the blood-brain barrier, they also underscore the value of quantifying delivery in the CNS with cell-type resolution instead of whole-tissue resolution.

引用

页码：9126 / 9134

页数：9

共 50 条

[41] The Blood-Brain Barrier
Campbell, Andrew W.
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2016, 22 (02) : 6 - 8
[42] Significance of Lipid Composition in a Blood-Brain Barrier-Mimetic PAMPA Assay
Campbell, Scott D.
Regina, Karen J.
Kharasch, Evan D.
JOURNAL OF BIOMOLECULAR SCREENING, 2014, 19 (03) : 437 - 444
[43] Functional Expression of Choline Transporters in the Blood-Brain Barrier
Inazu, Masato
NUTRIENTS, 2019, 11 (10)
[44] Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier
Zhang, Jun
Yang, Ting
Huang, Wan
Yu, Yao
Sun, Taolei
CURRENT MEDICINAL CHEMISTRY, 2022, 29 (39) : 6063 - 6083
[45] Glial regulation of the blood-brain barrier in health and disease
Broux, Bieke
Gowing, Elizabeth
Prat, Alexandre
SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (06) : 577 - 590
[46] The Blood-Brain Barrier
Felix Dyrna
Sophie Hanske
Martin Krueger
Ingo Bechmann
Journal of Neuroimmune Pharmacology, 2013, 8 : 763 - 773
[47] ABC transporters at the blood-brain barrier
Mahringer, Anne
Fricker, Gert
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (05) : 499 - 508
[48] In vitro models for the blood-brain barrier
Garberg, P
Ball, M
Borg, N
Cecchelli, R
Fenart, L
Hurst, RD
Lindmark, T
Mabondzo, A
Nilsson, JE
Raub, TJ
Stanimirovic, D
Terasaki, T
Öberg, JO
Österberg, T
TOXICOLOGY IN VITRO, 2005, 19 (03) : 299 - 334
[49] Development of the Blood-Brain Barrier in Ducks
Yang, Sheng
Wu, Jingxian
Shi, Yonghong
Huang, Yufei
Zhang, Yafei
Chen, Qiusheng
MICROSCOPY AND MICROANALYSIS, 2022, 28 (02) : 504 - 514
[50] Toxoplasma gondii and the blood-brain barrier
Feustel, Sabrina M.
Meissner, Markus
Liesenfeld, Oliver
VIRULENCE, 2012, 3 (02) : 182 - 192

← 1 2 3 4 5 →